keyboard_arrow_up

Critical Limb Ischemia Clinical Trials Market Review H2 2014

“Critical Limb Ischemia Global Clinical Trials Review, H2, 2014″ provides data on the Critical Limb Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Critical Limb Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Critical Limb Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

List of Tables

Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Region, 2014* 7

Critical Limb Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

Critical Limb Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10

Critical Limb Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11

Critical Limb Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12

Critical Limb Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13

Critical Limb Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14

Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15

Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16

Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17

Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18

Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19

Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20

Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Phase, 2014* 21

Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22

Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Critical Limb Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24

Critical Limb Ischemia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25

Critical Limb Ischemia Therapeutics, Global, Terminated Clinical Trials, 2014* 26

Critical Limb Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28

Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29

Critical Limb Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30

Critical Limb Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31

Critical Limb Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2014* 35

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ViroMed Co., Ltd., 2014* 36

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2014* 37

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 38

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2014* 39

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by TheraVitae Inc., 2014* 40

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ReNeuron Group plc, 2014* 41

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Intrexon Corporation, 2014* 42

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 43

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aastrom Biosciences, Inc., 2014* 44

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion Progreso y Salud, 2014* 45

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014* 46

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts University, 2014* 47

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 48

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansai Rosai Hospital, 2014* 49

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Biomedical Research and Innovation Hospital, 2014* 50

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 51

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by CHU de Reims, 2014* 52

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bern, 2014* 53

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2014* 54

To get Discount on this report, visit: http://www.rnrmarketresearch.com/contacts/discount?rname=249962 .

This is a premium report priced at US$2500 for a single user PDF.

Scope

·         Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

·         Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

·         Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

·         Understand the dynamics of a particular indication in a condensed manner

·         Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

·         Obtain discontinued trial listing for trials across the globe

·         Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies